Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
- PMID: 8627711
- PMCID: PMC190014
- DOI: 10.1128/JVI.70.3.1863-1872.1996
Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
Abstract
Forty-six monoclonal antibodies (MAbs) able to bind to the native, monomeric gp120 glycoprotein of the human immunodeficiency virus type 1 (HIV-1) LAI (HXBc2) strain were used to generate a competition matrix. The data suggest the existence of two faces of the gp120 glycoprotein. The binding sites for the viral receptor, CD4, and neutralizing MAbs appear to cluster on one face, which is presumably exposed on the assembled, oligomeric envelope glycoprotein complex. A second gp120 face, which is presumably inaccessible on the envelope glycoprotein complex, contains a number of epitopes for nonneutralizing antibodies. This analysis should be useful for understanding both the interaction of antibodies with the HIV-1 gp120 glycoprotein and neutralization of HIV-1.
Similar articles
-
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.
-
Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization.AIDS Res Hum Retroviruses. 1998 May 1;14(7):591-7. doi: 10.1089/aid.1998.14.591. AIDS Res Hum Retroviruses. 1998. PMID: 9591713
-
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443. Virology. 1997. PMID: 9126249
-
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.J Virol. 1997 Apr;71(4):2779-85. doi: 10.1128/JVI.71.4.2779-2785.1997. J Virol. 1997. PMID: 9060632 Free PMC article.
-
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.J Virol. 1995 Jan;69(1):222-30. doi: 10.1128/JVI.69.1.222-230.1995. J Virol. 1995. PMID: 7527084 Free PMC article.
Cited by
-
HIV N-linked glycosylation site analyzer and its further usage in anchored alignment.Nucleic Acids Res. 2013 Jul;41(Web Server issue):W454-8. doi: 10.1093/nar/gkt472. Epub 2013 Jun 8. Nucleic Acids Res. 2013. PMID: 23748959 Free PMC article.
-
Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.J Virol. 2005 Mar;79(6):3500-8. doi: 10.1128/JVI.79.6.3500-3508.2005. J Virol. 2005. PMID: 15731244 Free PMC article.
-
IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.AIDS Res Hum Retroviruses. 2010 Apr;26(4):445-58. doi: 10.1089/aid.2009.0223. AIDS Res Hum Retroviruses. 2010. PMID: 20377426 Free PMC article.
-
Comparing antigenicity and immunogenicity of engineered gp120.J Virol. 2005 Oct;79(19):12148-63. doi: 10.1128/JVI.79.19.12148-12163.2005. J Virol. 2005. PMID: 16160142 Free PMC article.
-
A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.J Virol. 2010 Apr;84(7):3147-61. doi: 10.1128/JVI.02587-09. Epub 2010 Jan 20. J Virol. 2010. PMID: 20089638 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials